Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Primary Care Patient Experience with Naloxone Prescription

Emily Behar, Christopher Rowe, Glenn-Milo Santos, Sheigla Murphy and Phillip O. Coffin
The Annals of Family Medicine September 2016, 14 (5) 431-436; DOI: https://doi.org/10.1370/afm.1972
Emily Behar
1San Francisco Department of Public Health, San Francisco, California
2University of California San Francisco, San Francisco, California
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Emily.behar@sfdph.org
Christopher Rowe
1San Francisco Department of Public Health, San Francisco, California
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn-Milo Santos
1San Francisco Department of Public Health, San Francisco, California
2University of California San Francisco, San Francisco, California
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheigla Murphy
3Institute for Scientific Analysis, San Francisco, California
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip O. Coffin
1San Francisco Department of Public Health, San Francisco, California
2University of California San Francisco, San Francisco, California
MD, MIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Opioid safety and how to use naloxone. A guide for patients and caregivers.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1

    Demographic and Behavioral Characteristics of Primary Care Patients Prescribed Naloxone (N = 60)

    CharacteristicNo. (%)
    Sex, male33 (55)
    Race/ethnicity
     White16 (27)
     African American33 (55)
     Hispanic5 (8)
     Mixed/other6 (10)
    Prescribed opioids for pain52 (87)
    Ever taken opioids not as prescribed32 (53)
    Opioids currently prescribed, mean (SD)1.3 (0.8)
    Previously received take-home naloxone6 (10)
    Previously had heard of naloxone (n = 52)21 (40)
    Naloxone ever used on participant (n = 22)6 (27)
    History of overdose/bad reaction22 (37)
     Overdose12 (20)
     Bad reaction10 (17)
    Ever witnessed an opioid overdose32 (53)
    Perceived personal risk of overdose (n = 47)
     Low (<3)36 (77)
     Moderate (3–6)10 (21)
     High (>6)1 (2)
    • View popup
    Table 2

    Responses to Prescribed Naloxone Among Primary Care Patients (N = 60)

    ResponseNo. (%)
    Attempted to fill naloxone prescription56 (93)
    Able to fill naloxone prescription (n = 56)49 (88)
    Naloxone prescription from study used on participant3 (5)
    Site of storage for naloxone (n = 48)
     Store at home39 (81)
     Carry with me6 (13)
     Unsure of location/lost3 (6)
    Person(s) trained by participant to use naloxone (n = 49)
     Family18 (37)
     Roommate12 (24)
     Friend11 (22)
     Partner8 (16)
     Neighbor5 (10)
     Housing staff5 (10)
     Nobody15 (31)
    Participant confidence in ability to use naloxone (n = 49)
     Not at all confident2 (4)
     A little confident5 (10)
     Somewhat confident13 (26)
     Very confident29 (59)
    Participant confident person(s) they trained could use naloxone (n = 34)
     Not at all confident3 (9)
     A little confident1 (3)
     Somewhat confident9 (26)
     Very confident21 (62)
    • View popup
    Table 3

    Reactions to and Perceptions of Naloxone Prescription Among Primary Care Patients (N = 60)

    Perception and ReactionNo. (%)
    Reaction to naloxone prescription offer
     Positive34 (57)
     Negative13 (22)
     Neutral13 (22)
    Reasons for positive reaction to naloxone prescription offer (n = 34)
     Benefits the community18 (53)
     Appreciated it was offered14 (41)
     Improved relationship with provider10 (29)
    Reasons for negative reaction to naloxone prescription offer (n = 13)
     Prescription was undeserved10 (77)
     Judged by clinician9 (69)
     Scared8 (61)
     Offended by the prescription3 (23)
    Opioid-related behavior modification since receiving naloxone
     Positive22 (37)
     Neutral38 (63)
     Negative0 (0)
    Type of positive behavior modification (n = 8)
     Improved dosing7 (88)
     Improved timing7 (88)
     Improved knowledge around opioids and overdose5 (63)
     Decrease in polysubstance use1 (12)
     Decrease in using alone1 (12)
    Would want naloxone prescription in the future (n = 59)
     Yes56 (95)
     No1 (2)
     Do not know2 (3)
    Naloxone should be available to patients prescribed opioids for pain (n = 59)
     Yes, all47 (80)
     Yes, some10 (17)
     No0 (0)
     Do not know2 (3)

Additional Files

  • Figures
  • Tables
  • Supplemental Appendix

    Supplemental Appendix

    Files in this Data Supplement:

    • Supplemental data: Appendix - PDF file
  • The Article in Brief

    Primary Care Patient Experience With Naloxone Prescription

    Emily Behar , and colleagues

    Background Drug overdose, driven by opioids, is the leading cause of accidental death in the United States, but distribution of the opioid antagonist naloxone (which blocks or reduces the opioid's effects) has been associated with a reduction in opioid overdose mortality. This is the first study to evaluate patients' experiences receiving a co-prescription of naloxone with opioids.

    What This Study Found Patients overwhelmingly responded positively to being offered a naloxone prescription, and having naloxone was associated with beneficial changes in their opioid use behaviors. Interviews with 60 patients who received naloxone prescriptions across 6 safety-net primary care clinics revealed that 90 percent of patients had never previously received a naloxone prescription, 88 percent successfully filled the prescription, 97 percent believed patients prescribed opioids should be offered naloxone, 79 percent had a positive or neutral response to being offered naloxone and 37 percent reported positive behavior change after receiving the prescription (safer dosing, safer timing and increased knowledge around opioids and overdose). Although 37 percent of patients described having previously overdosed, 17 percent of those patients described the events as ?bad reactions,? and 77 percent estimated their risk of overdose as low.

    Implications

    • The authors suggest that improved terminology is needed to describe opioid poisonings, as the term "overdose" may not reflect patients' perceptions.
    • Since 90 percent of patients in this study had never previously received a naloxone prescription, the authors conclude that primary care prescribing appears to be reaching a population not served by community distribution. They call for future studies to investigate strategies to maximize the positive effects of on behavior change and to integrate naloxone prescribing with broader opioid stewardship efforts.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 14 (5)
The Annals of Family Medicine: 14 (5)
Vol. 14, Issue 5
September/October 2016
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Primary Care Patient Experience with Naloxone Prescription
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Primary Care Patient Experience with Naloxone Prescription
Emily Behar, Christopher Rowe, Glenn-Milo Santos, Sheigla Murphy, Phillip O. Coffin
The Annals of Family Medicine Sep 2016, 14 (5) 431-436; DOI: 10.1370/afm.1972

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Primary Care Patient Experience with Naloxone Prescription
Emily Behar, Christopher Rowe, Glenn-Milo Santos, Sheigla Murphy, Phillip O. Coffin
The Annals of Family Medicine Sep 2016, 14 (5) 431-436; DOI: 10.1370/afm.1972
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • 'Do they care?: a qualitative examination of patient perspectives on primary care clinician communication related to opioids in the USA
  • Updating our language around substance use disorders
  • In This Issue: Different Paths to Discovery
  • Google Scholar

More in this TOC Section

  • Family-Based Interventions to Promote Weight Management in Adults: Results From a Cluster Randomized Controlled Trial in India
  • Teamwork Among Primary Care Staff to Achieve Regular Follow-Up of Chronic Patients
  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Acute illness
    • Chronic illness
    • Mental health
  • Person groups:
    • Vulnerable populations
  • Methods:
    • Quantitative methods

Keywords

  • naloxone
  • opioid overdose
  • clinic-based prescribing

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine